Text & Content Analysis
This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
Explore by Category
Corpus KPIs
Entity
al-aly
Articles
1
From
2026-03-18 16:01:26+00
To
2026-03-18 16:01:26+00
Range
2026-02-16 21:29:41.680408+00 →
2026-03-18 21:29:41.680408+00
Who’s being talked about
Top Entities
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| about two | CARDINAL | 1 | 📊 🔍 🧲 |
| alaly | PERSON | 1 | 📊 🔍 🧲 |
| bmj medicine | ORG | 1 | 📊 🔍 🧲 |
| eli lillys | ORG | 1 | 📊 🔍 🧲 |
| featured weekly ad | WORK_OF_ART | 1 | 📊 🔍 🧲 |
| food and drug administration | ORG | 1 | 📊 🔍 🧲 |
| glp1 | PRODUCT | 1 | 📊 🔍 🧲 |
| glp1s | PERSON | 1 | 📊 🔍 🧲 |
| ken alltucker usa | PERSON | 1 | 📊 🔍 🧲 |
| kff | ORG | 1 | 📊 🔍 🧲 |
| less than 1 | PERCENT | 1 | 📊 🔍 🧲 |
| lilly | ORG | 1 | 📊 🔍 🧲 |
| mercer | PERSON | 1 | 📊 🔍 🧲 |
| mounjaro | PERSON | 1 | 📊 🔍 🧲 |
| novo | ORG | 1 | 📊 🔍 🧲 |
| novo nordisks | ORG | 1 | 📊 🔍 🧲 |
| one | CARDINAL | 1 | 📊 🔍 🧲 |
| ozempic | ORG | 1 | 📊 🔍 🧲 |
| ozempic and glp1s | WORK_OF_ART | 1 | 📊 🔍 🧲 |
| truveta | GPE | 1 | 📊 🔍 🧲 |
| va | ORG | 1 | 📊 🔍 🧲 |
| veterans affairs | ORG | 1 | 📊 🔍 🧲 |
| washington university school of medicine | ORG | 1 | 📊 🔍 🧲 |
| wegovy | PERSON | 1 | 📊 🔍 🧲 |
| ziyad alaly | PERSON | 1 | 📊 🔍 🧲 |
Articles included
Top entities
Top sources
Top narrative frames
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-03-18 16:01:26+00 | Health |
|
Why quitting Ozempic and GLP-1s can be bad for your heart health | Analyze | Ken Alltucker | 😐 neutral | 0.0696 |